UNSPSC 51282507: Cefroxadine

This classification denotes a cephalosporin antibiotic with the molecular formula C16H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B908C4MV2R, chemically known as 7-(d-2-amino-2-(1,4-cyclohexadienyl)acetamide)-3-methoxy-3-cephem-4-carboxylic acid but generally known as cefroxadine, which bears US NIH Compound Identifier 40117. European Medicines Agency schedules Cefroxadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07419MIG.

UNSPSC 51282507 Cefroxadine (Commodity) does not align with the state and local procurement activity currently tagged under this code. The recent opportunities show minimal relevant activity — one solicitation appears mislabeled and three recent opportunities address naloxone, first aid supplies, and generic pharmaceuticals, none of which match the specific antibiotic product identified in the code name. State and local governments soliciting under this code appear to be sourcing broad pharmaceutical and medical supply categories rather than the targeted commodity the UNSPSC designation suggests. The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire and rescue services (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance).

Geographic activity spans Florida, Texas, and Minnesota-led multistate purchasing, though the limited sample size and code misalignment suggest the code is not a primary vehicle for state and local procurement at this time. Representative recent opportunities include Seminole County's IFB 60459723LAS for 1,900 units of naloxone annually (due July 26, 2026), the City of Tampa's IFB 26P00145 for medical and first aid supplies for the Fire Department Rescue Division estimated at $700,000 (due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The source shows no recent opportunities specifically soliciting cefroxadine or closely related products, indicating limited current demand under this Commodity code in state and local markets.